Asia-Pacific Next Generation Sequencing (NGS) Market to 2032
Overview
The Asia-Pacific Next Generation Sequencing (NGS) Market is expected to reach a 9,046.72 USD Billion by 2032 and is projected to grow at a CAGR of 20.61% from 2025 to 2032.
Revenue, 2024 (USD Billion)
3,091.82
Forecast, 2032 (USD Billion)
9,046.72
CAGR, 2024 - 2032
20.61%
Report Coverage
Asia-Pacific
Asia-Pacific Next Generation Sequencing (NGS) Market 2018-2032 USD Billion
Asia-Pacific Next Generation Sequencing (NGS) Market, Key Findings (2025-2032)
Market Growth and Projections:
- Market Size (2024): 3,091.82 USD Billion
- Projected Market Size (2032): 9,046.72 USD Billion
- CAGR (2025-2032): 20.61%
Key Findings of Asia-Pacific Next Generation Sequencing (NGS) Market
- The Asia-Pacific Next Generation Sequencing (NGS) Market was valued at 3,091.82 USD Billion in 2024.
- The Asia-Pacific Next Generation Sequencing (NGS) Market is likely to grow at a CAGR of 20.61% during the forecast period of 2024 to 2032.
- In 2024, the Largest segment Drug & Biomarker Discovery in Application Segment accounted for the largest share of the market with a revenue of 3,091.82 USD Billion
- The fastest growing segment Pharmaceuticals Microbiology in Application Segment grew Fastest with a CAGR of 21.76% during the forecast period from 2024 to 2032.
Asia-Pacific Next Generation Sequencing (NGS) Market Scope
Asia-Pacific Next Generation Sequencing (NGS) Market Segmentation & Scope
Distribution Channel
- Others
- Retail Sales
- Direct Tender
Application
- Others
- Food Pathogen Screening
- Agricultural & Animal Research
- Diagnostics
- Pharmaceuticals Microbiology
- Drug & Biomarker Discovery
- Precision Medicine
Technology
- Others
- Sequencing By Ligation (SBL)
- Sequencing By Synthesis (SBS)
Product & Service
- Instruments
- Services
- Consumables
End User
- Others
- Contract Research Organizations (CROS)
- Clinical Laboratories
- Hospitals & Clinics
- Academic & Research Institutes
- Pharmaceutical & Biotechnology Companies
Asia-Pacific Next Generation Sequencing (NGS) Market Data Coverage Insights
| Study Period | 2024-2032 |
| Base Year | 2020 |
| Unit | Revenue in USD Billion |
| Market Value in 2024 | 3,091.82 USD Billion |
| Market Value in 2032 | 9,046.72 USD Billion |
| CAGR (2025-2032) | 20.61% |
| Historic Data | 2016-2023 |
| Market Segments Covered | Distribution Channel,Application,Technology,Product & Service,End User |
Regional Insights:
-
Leading Market (2024-2032): Asia-Pacific, leading in terms of revenue 3,091.82 USD Billion in 2024
- Key Country: China, leading in terms of revenue with value of 595.12 USD Billion in 2024.
Segments and Scope
-
Asia-Pacific Next Generation Sequencing (NGS) Market to 2032, By Distribution Channel
- Direct Tender is the largest segment in Asia-Pacific Next Generation Sequencing (NGS) Market to 2032 with a revenue of 1,902.24 USD Billion in the year 2024.
- Direct Tender is the Fastest growing segment in Asia-Pacific Next Generation Sequencing (NGS) Market to 2032 with a Growth rate of 20.82 % in forecast period 2025-2032.
-
Asia-Pacific Next Generation Sequencing (NGS) Market to 2032, By Application
- Drug & Biomarker Discovery is the largest segment in Asia-Pacific Next Generation Sequencing (NGS) Market to 2032 with a revenue of 3,091.82 USD Billion in the year 2024.
- Pharmaceuticals Microbiology is the Fastest growing segment in Asia-Pacific Next Generation Sequencing (NGS) Market to 2032 with a Growth rate of 20.61 % in forecast period 2025-2032.
-
Asia-Pacific Next Generation Sequencing (NGS) Market to 2032, By Technology
- Sequencing By Synthesis (SBS) is the largest segment in Asia-Pacific Next Generation Sequencing (NGS) Market to 2032 with a revenue of 1,914.80 USD Billion in the year 2024.
- Sequencing By Synthesis (SBS) is the Fastest growing segment in Asia-Pacific Next Generation Sequencing (NGS) Market to 2032 with a Growth rate of 20.90 % in forecast period 2025-2032.
-
Asia-Pacific Next Generation Sequencing (NGS) Market to 2032, By Product & Service
- Consumables is the largest segment in Asia-Pacific Next Generation Sequencing (NGS) Market to 2032 with a revenue of 1,596.05 USD Billion in the year 2024.
- Services is the Fastest growing segment in Asia-Pacific Next Generation Sequencing (NGS) Market to 2032 with a Growth rate of 20.47 % in forecast period 2025-2032.
-
Asia-Pacific Next Generation Sequencing (NGS) Market to 2032, By End User
- Pharmaceutical & Biotechnology Companies is the largest segment in Asia-Pacific Next Generation Sequencing (NGS) Market to 2032 with a revenue of 1,264.20 USD Billion in the year 2024.
- Pharmaceutical & Biotechnology Companies is the Fastest growing segment in Asia-Pacific Next Generation Sequencing (NGS) Market to 2032 with a Growth rate of 21.46 % in forecast period 2025-2032.
Asia-Pacific Next Generation Sequencing (NGS) Market Company Share Analysis
| Company Name |
|
||
| Merck KGaA | |||
| Thermo Fisher Scientific Inc. | |||
| QIAGEN | |||
| Charles River Laboratories | |||
Asia-Pacific Next Generation Sequencing (NGS) Market Geographical Sales Distribution, 2018-2032 USD Billion
Asia-Pacific Next Generation Sequencing (NGS) Market Company Profiling
Industry Related Reports
Frequently Asked Questions
The Asia-Pacific Next Generation Sequencing (NGS) Market is segmented based on Segmentation Distribution Channel,Application,Technology,Product & Service,End User.
Asia-Pacific Next Generation Sequencing (NGS) Market was valued at USD 3,091.82(Revenue in USD Billion) in 2020.
Asia-Pacific Next Generation Sequencing (NGS) Market is projected to grow at a CAGR of 20.61% during the forecast period of 2024 to 2032.
The Drug & Biomarker Discovery segment is expected to dominate the Asia-Pacific Next Generation Sequencing (NGS) Market, holding a largest market share of 3,091.82 USD Billion in 2024
Coming Soon....
Asia-Pacific Next Generation Sequencing (NGS) Market Scope
Asia-Pacific Next Generation Sequencing (NGS) Market Segmentation & Scope
Distribution Channel
- Others
- Retail Sales
- Direct Tender
Application
- Others
- Food Pathogen Screening
- Agricultural & Animal Research
- Diagnostics
- Pharmaceuticals Microbiology
- Drug & Biomarker Discovery
- Precision Medicine
Technology
- Others
- Sequencing By Ligation (SBL)
- Sequencing By Synthesis (SBS)
Product & Service
- Instruments
- Services
- Consumables
End User
- Others
- Contract Research Organizations (CROS)
- Clinical Laboratories
- Hospitals & Clinics
- Academic & Research Institutes
- Pharmaceutical & Biotechnology Companies
Frequently Asked Questions
The Asia-Pacific Next Generation Sequencing (NGS) Market is segmented based on Segmentation Distribution Channel,Application,Technology,Product & Service,End User.
Asia-Pacific Next Generation Sequencing (NGS) Market was valued at USD 3,091.82(Revenue in USD Billion) in 2020.
Asia-Pacific Next Generation Sequencing (NGS) Market is projected to grow at a CAGR of 20.61% during the forecast period of 2024 to 2032.
The estimated market value of the Asia-Pacific Next Generation Sequencing (NGS) Market for final year is USD 9,046.72 (USD Billion).
Asia-Pacific Next Generation Sequencing (NGS) Market Company Profiling
Frequently Asked Questions
The Asia-Pacific Next Generation Sequencing (NGS) Market is segmented based on Segmentation Distribution Channel,Application,Technology,Product & Service,End User.
Asia-Pacific Next Generation Sequencing (NGS) Market was valued at USD 3,091.82(Revenue in USD Billion) in 2020.
Asia-Pacific Next Generation Sequencing (NGS) Market is projected to grow at a CAGR of 20.61% during the forecast period of 2024 to 2032.
The estimated market value of the Asia-Pacific Next Generation Sequencing (NGS) Market for final year is USD 9,046.72 (USD Billion).
HAVE A QUESTION?
Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.